CURE Pharmaceutical Attracts Strategic Investment to Speed Its Cannabinoid Drug Delivery Production

GlobeNewswire May 1, 2018 OXNARD, Calif., May 01, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it received an investment of $500,000 from a strategic partner to advance its cannabinoid-based drug delivery product line. This investment comes from a pharmaceutical partner in the form of a convertible…